|
MedChemExpress
glesatinib Glesatinib, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/glesatinib/product/MedChemExpress Average 93 stars, based on 1 article reviews
glesatinib - by Bioz Stars,
2026-05
93/100 stars
|
Buy from Supplier |
|
TargetMol
mgcd 265 analog Mgcd 265 Analog, supplied by TargetMol, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/mgcd 265 analog/product/TargetMol Average 93 stars, based on 1 article reviews
mgcd 265 analog - by Bioz Stars,
2026-05
93/100 stars
|
Buy from Supplier |
|
Selleck Chemicals
657 24 9 mgcd 265 selleck s1361 657 24 9 Mgcd 265 Selleck S1361, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/657 24 9 mgcd 265 selleck s1361/product/Selleck Chemicals Average 93 stars, based on 1 article reviews
657 24 9 mgcd 265 selleck s1361 - by Bioz Stars,
2026-05
93/100 stars
|
Buy from Supplier |
|
MethylGene Inc
mgcd265 Mgcd265, supplied by MethylGene Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/mgcd265/product/MethylGene Inc Average 90 stars, based on 1 article reviews
mgcd265 - by Bioz Stars,
2026-05
90/100 stars
|
Buy from Supplier |
|
Mirati Therapeutics
glesatinib mgcd265  Glesatinib Mgcd265, supplied by Mirati Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/glesatinib mgcd265/product/Mirati Therapeutics Average 90 stars, based on 1 article reviews
glesatinib mgcd265 - by Bioz Stars,
2026-05
90/100 stars
|
Buy from Supplier |
|
MultiTarget Pharmaceuticals
mgcd265  Mgcd265, supplied by MultiTarget Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/mgcd265/product/MultiTarget Pharmaceuticals Average 90 stars, based on 1 article reviews
mgcd265 - by Bioz Stars,
2026-05
90/100 stars
|
Buy from Supplier |
|
Cayman Chemical
mgcd-265 20097 Mgcd 265 20097, supplied by Cayman Chemical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/mgcd-265 20097/product/Cayman Chemical Average 90 stars, based on 1 article reviews
mgcd-265 20097 - by Bioz Stars,
2026-05
90/100 stars
|
Buy from Supplier |
|
InformationMGCD-265 is a potent, multi-target and ATP-competitive inhibitor ofc-MetandVEGFR1/2/3withIC50of 1 nM, 3 nM/3 nM/4 nM, respectively; also inhibits Ron and Tie2. Phase 1/2.In vitroMGCD-265 is a multi-target inhibitor of receptor tyrosine kinases. MGCD-265 potently inhibits
|
Buy from Supplier |
|
MGCD-265 analog is a potent and oral bioavailable inhibitor of c-Met and VEGFR2 tyrosine kinases, with IC50 s of 29 nM and 10 nM, respectively. MGCD-265 analog has significant antitumor activity.
|
Buy from Supplier |
|
MGCD-265 is a potent, multi-target, and ATP-competitive receptor tyrosine kinase inhibitor of Met, Flt-1, Flt-4, Flk-1, Ron, and Tie-2 (IC50 = 1 nM - 7 nM).
|
Buy from Supplier |
|
Application：MGCD-265 analog is a potent and oral active inhibitor of c-Met and VEGFR2 tyrosine kinases, with IC50s of 29 nM and 10 nM, respectively. MGCD-265 analog has significant antitumor activity
|
Buy from Supplier |
|
MGCD-265 is a potent, multi-target and ATP-competitive inhibitor of c-Met and VEGFR1/2/3 with IC50 of 1 nM, 3 nM/3 nM/4 nM, respectively and also inhibits Ron and Tie2.
|
Buy from Supplier |
Image Search Results
Journal: International Journal of Molecular Sciences
Article Title: Therapeutic Targeting of the Gas6/Axl Signaling Pathway in Cancer
doi: 10.3390/ijms22189953
Figure Lengend Snippet: Type II kinase inhibitors against Axl.
Article Snippet:
Techniques: In Vitro
Journal: Cold Spring Harbor Molecular Case Studies
Article Title: Personalized oncogenomic analysis of metastatic adenoid cystic carcinoma: using whole-genome sequencing to inform clinical decision-making
doi: 10.1101/mcs.a002626
Figure Lengend Snippet: POG analyses in all five adenoid cystic carcinoma cases yielded informative and actionable results
Article Snippet: Patient 3 exhibited aberrations in MET expression and was subsequently enrolled in a phase I clinical trial with
Techniques: Biomarker Discovery, Over Expression